Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Johnson and Johnson
McKesson
McKinsey
Colorcon

Last Updated: August 8, 2022

Investigational Drug Information for SGI-1776


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for SGI-1776?

SGI-1776 is an investigational drug.

There have been 27 clinical trials for SGI-1776. The most recent clinical trial was a Phase 3 trial, which was initiated on March 16th 2017.

The most common disease conditions in clinical trials are Leukemia, Myeloid, Acute, Leukemia, and Leukemia, Myeloid. The leading clinical trial sponsors are Astex Pharmaceuticals, Astex Pharmaceuticals, Inc., and National Cancer Institute (NCI).

There are fifteen US patents protecting this investigational drug and sixty-eight international patents.

Recent Clinical Trials for SGI-1776
TitleSponsorPhase
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional ChondrosarcomaNational Cancer Institute (NCI)Phase 2
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal CancerAstex PharmaceuticalsPhase 1/Phase 2
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal CancerAstex Pharmaceuticals, Inc.Phase 1/Phase 2

See all SGI-1776 clinical trials

Clinical Trial Summary for SGI-1776

Top disease conditions for SGI-1776
Top clinical trial sponsors for SGI-1776

See all SGI-1776 clinical trials

US Patents for SGI-1776

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SGI-1776 See Plans and Pricing Bicyclic fused pyrimidine compounds as TAM inhibitors Incyte Corporation (Wilmington, DE) See Plans and Pricing
SGI-1776 See Plans and Pricing Pyrrolopyrimidine derivatives as TAM inhibitors Incyte Corporation (Wilmington, DE) See Plans and Pricing
SGI-1776 See Plans and Pricing Pyrazolopyridine compounds and uses thereof Incyte Corporation (Wilmington, DE) See Plans and Pricing
SGI-1776 See Plans and Pricing Pyrazolopyridone compounds and uses thereof Incyte Corporation (Wilmington, DE) See Plans and Pricing
SGI-1776 See Plans and Pricing Pyrazolopyridine compounds and uses thereof Incyte Corporation (Wilmington, DE) See Plans and Pricing
SGI-1776 See Plans and Pricing Pyrrolotriazine compounds as TAM inhibitors Incyte Corporation (Wilmington, DE) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for SGI-1776

Drugname Country Document Number Estimated Expiration Related US Patent
SGI-1776 World Intellectual Property Organization (WIPO) WO2017027717 2035-08-12 See Plans and Pricing
SGI-1776 World Intellectual Property Organization (WIPO) WO2017035366 2035-08-26 See Plans and Pricing
SGI-1776 Argentina AR109596 2036-09-09 See Plans and Pricing
SGI-1776 Australia AU2017322427 2036-09-09 See Plans and Pricing
SGI-1776 Brazil BR112019004586 2036-09-09 See Plans and Pricing
SGI-1776 Canada CA3036358 2036-09-09 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Johnson and Johnson
McKesson
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.